Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
83%(10 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_3
5
38%
Ph phase_1
7
54%

Phase Distribution

7

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
7(53.8%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
5(38.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(12)

Detailed Status

Completed12
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 17 (53.8%)
Phase 21 (7.7%)
Phase 35 (38.5%)

Trials by Status

not_yet_recruiting18%
completed1292%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT07371429Phase 1

A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics

Not Yet Recruiting
NCT06597344Phase 3

A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

Completed
NCT05630833Phase 3

A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Completed
NCT04484740Phase 1

Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue

Completed
NCT04010539Phase 3

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

Completed
NCT04187144Phase 3

Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)

Completed
NCT04020341Phase 3

A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)

Completed
NCT05271799Phase 1

A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants

Completed
NCT04493931Phase 1

Drug-drug Interaction Study of Gepotidacin

Completed
NCT03562117Phase 1

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Completed
NCT04079790Phase 1

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

Completed
NCT02729038Phase 1

Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function

Completed
NCT03568942Phase 2

Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13